<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib1115">
 <label>223</label>
 <element-citation publication-type="journal" id="sbref1115">
  <person-group person-group-type="author">
   <name>
    <surname>Xiong</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Borrego</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Ding</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Martins</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Chong</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>A helical short-peptide fusion inhibitor with highly potent activity against human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus</article-title>
  <source>J. Virol.</source>
  <volume>91</volume>
  <issue>1</issue>
  <year>2017</year>
 </element-citation>
</ref>
